Anti-VEGF and anti-complement therapies work on distinct mechanisms in age-related macular degeneration, and both may be required to treat patients with advanced disease or complex cases.

The AI rally is back and this time its not Nvidia. This is the ultimate AI stock to buy for under $200. Here's why.

Why it's time to sell or trim. Gain insights on short-term corrections & 12-month outlook. Click for my AMD update.

Over 100 major companies — including MicroStrategy, Coinbase, AMD, Pfizer, and Boeing — are set to report earnings today, July 31. From crypto and AI to healthcare and industrials, here's the full ...

Advanced Micro Devices Inc. (AMD) just received a bullish upgrade from UBS, hiking its price target to $210 from $150 while ...

Qualcomm, the world's largest supplier of modem chips and seen as a bellwether for smartphones, said chip sales to non-Apple ...

Bank of America has raised its price target on AMD to $200 from $175, maintaining a Buy rating ahead of the earnings report.

Several growth stocks are scheduled to announce their second-quarter earnings in the upcoming weeks. Despite macro challenges ...

Terry Richardson, a 40-year tech industry veteran, is retiring as CRO of Blue Mantis, with Scott Pintsopoulos taking the role ...

AMDY's aggressive covered call strategy generates high income but may underperform AMD shares in strong bull markets. Read ...

Buying $100 In AMD: If an investor had bought $100 of AMD stock 5 years ago, it would be worth $228.17 today based on a price of $176.64 for AMD at the time of writing.

Advanced Micro Devices, Inc. (NASDAQ: AMD) is one of the Trending AI Stocks on Wall Street. On July 23, Erste Group upgraded ...